Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Gildan Activewear (GIL) raises C$700M through senior unsecured notes to refinance credit facilities and support corporate ...

Arrowhead's ARO-C3 cut C3 levels by up to 89% and proteinuria by 41% in a Phase 1/2 trial. Additional results will be ...

Loop Capital founder Jim Reynolds​​​​ expects municipalities to sell as much as $600 billion of bonds this year. The market ...

Novo Nordisk's REDEFINE 2 trial shows CagriSema led to significant weight loss in patients with obesity and type 2 diabetes. Regulatory filing is planned for 2026.

Loop Capital founder Jim Reynolds​​​​ expects municipalities to sell as much as $600 billion of bonds this year. The market ...

PB Fintech and its cofounders are looking to invest up to INR 828.75 Cr ($95 Mn) in healthcare arm PB Healthcare Services Pvt ...

The borrowings are likely to be 20.89 per cent of the projected ₹30.77 trillion GSDP in FY26, against ₹5.96 trillion per the ...

Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results ...

According to DHL’s statement, it employs approximately 602,000 people in more than 220 countries and territories across the ...

Electronics manufacturers in India, including Apple's vendors, fear US tariffs, potential shift to China or Vietnam, ...

The medical devices company reported adjusted EPS of $3.89, beating the consensus of $3.86. Guidance: Teleflex expects 2025 ...